{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:20:02Z","timestamp":1793053202175,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4590,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.fertnstert.2008.08.127","type":"journal-article","created":{"date-parts":[[2008,10,19]],"date-time":"2008-10-19T04:08:01Z","timestamp":1224389281000},"page":"1586-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"title":["Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization"],"prefix":"10.1016","volume":"92","author":[{"given":"Luciano G.","family":"Nardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A.","family":"Gelbaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.08.127_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib2","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/humrep\/14.11.2681","article-title":"Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks","volume":"14","author":"Fauser","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(96)05291-9","article-title":"Factors that affect outcome of in-vitro fertilization outcome","volume":"348","author":"Templeton","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0015-0282(16)58634-8","article-title":"Age-dependent decrease in embryo implantation rate after in vitro fertilization","volume":"66","author":"van Kooij","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive aging","volume":"8","author":"te Velde","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmm034","article-title":"Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation","volume":"14","author":"Fauser","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/rep.1.01178","article-title":"Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary","volume":"132","author":"Modi","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib10","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ydbio.2003.10.009","article-title":"Oocyte regulation and anti-mullerian hormone expression in granulosa cells during ovarian follicle development in mice","volume":"266","author":"Salmon","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib14","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-M\u00fcllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib17","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","article-title":"High reproducibility of serum anti-M\u00fcllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status","volume":"20","author":"Fanchin","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/humrep\/dei499","article-title":"Dynamics of FSH-induced follicular growth in subfertile women: a relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone","volume":"21","author":"Fleming","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","article-title":"Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol","volume":"82","author":"Hazout","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib22","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","article-title":"Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF\/ICSI patients?","volume":"111","author":"Muttukrishna","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment","volume":"20","author":"Penarrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","article-title":"Anti-m\u00fcllerian hormone as a marker of ovarian reserve","volume":"45","author":"Tremellen","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib25","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib26","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","author":"Broer","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(99)00238-5","article-title":"Follicle dynamics during ovarian ageing","volume":"163","author":"Faddy","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib29","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/oxfordjournals.humrep.a136217","article-title":"High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome","volume":"10","author":"Kodama","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/humrep\/14.1.167","article-title":"The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology","volume":"14","author":"Engmann","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib31","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/deg451","article-title":"Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study","volume":"18","author":"Bellver","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib32","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antimullerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2005.10.052","article-title":"Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization","volume":"85","author":"Nakhuda","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/humrep\/del421","article-title":"Anti-M\u00fcllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","volume":"22","author":"La Marca","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib37","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib38","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2007.04.054","article-title":"Statistically significant changes of antim\u00fcllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women","volume":"89","author":"Wunder","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2006.06.013","article-title":"Measurement of serum anti-M\u00fcllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART)","volume":"375","author":"Fr\u00e9our","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1023\/A:1009422323306","article-title":"Effects of aging on ovarian fecundity in terms of the incidence of apoptotic granulosa cells","volume":"17","author":"Sadraie","year":"2000","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib42","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib43","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-M\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.fertnstert.2004.11.005","article-title":"The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization","volume":"83","author":"Klinkert","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.08.127_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750.pub2","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","volume":"3","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208038375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208038375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:33:02Z","timestamp":1758007982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208038375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0015028208038375"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.08.127","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.08.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}